why choose us

First received: August 18, 2024

Clinical Trial: A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Venous and Arterial Thrombotic and Thromboembolic Events

Study Type: INTERVENTIONAL


Official Title: A Single Dose Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAY 3018250 After Intravenous Infusion in Healthy Male Japanese Participants in a Dose Escalation Desi

Brief Summary: Researchers are looking for a better way to treat people who have acute venous and arterial thrombotic and thromboembolic events.These are severe medical problems due to blood clots forming in and blocking blood vessels.The study treatment BAY3018250 is under development to treat acute venous and arterial thrombotic and thromboembolic events.It aims to work by dissolving blood clots in the blood vessels.In this study, participants will be healthy and will not benefit from receiving BAY3018250.However, the study…

Read more